Klemastin: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
Muhammad Anas Sidik (bicara | kontrib)
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
 
Baris 91:
* [https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682542.html NIH Medline Plus listing on Clemastine]
* [https://web.archive.org/web/20070310064609/http://jcp.sagepub.com/cgi/content/abstract/36/10/911 The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations]
[[Kategori:Senyawa 4-klorofenil]]
[[Category:4-Chlorophenyl compounds]]
[[Kategori:Penghambat CYP2D6]]
[[Category:CYP2D6 inhibitors]]
[[Kategori:Eter difenilmetanol]]
[[Category:Diphenylmethanol ethers]]
[[Kategori:Antagonis reseptor H1]]
[[Category:H1 receptor antagonists]]
[[Kategori:Antagonis muskarinik]]
[[Category:Muscarinic antagonists]]
[[Kategori:Pirolidina]]
[[Category:Pyrrolidines]]